Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MBX Biosciences, Inc. | 727,667 | reported | 06 May 2026 | tx 19+1,263,073−5,018,224 |
| MetaVia Inc. | 10,800 | reported | 29 Jan 2018 | tx 10+171,439−7,457 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 May 2026 | SALE | MBX Biosciences, Inc. | 607 | 29.54 USD | |
| 13 Mar 2026 | PURCHASE | MBX Biosciences, Inc. | 18,500 | 28.41 USD | |
| 26 Feb 2026 | EXERCISE | MBX Biosciences, Inc. | 28,768 | 16.00 USD | |
| 26 Feb 2026 | EXERCISE | MBX Biosciences, Inc. | 28,768 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | MBX Biosciences, Inc. | 35,250 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | MBX Biosciences, Inc. | 164,500 | 0.00 USD | deriv |
| 24 Oct 2025 | EXERCISE | MBX Biosciences, Inc. | 182,859 | 3.25 USD | |
| 24 Oct 2025 | EXERCISE | MBX Biosciences, Inc. | 182,859 | 0.00 USD | deriv |
| 20 Oct 2025 | PURCHASE | MBX Biosciences, Inc. | 20,000 | 13.64 USD | |
| 04 Feb 2025 | PURCHASE | MBX Biosciences, Inc. | 50,000 | 10.69 USD | first after silence |
| 03 Feb 2025 | GRANT_AWARD | MBX Biosciences, Inc. | 243,000 | 0.00 USD | deriv |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 283,846 | — | |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 115,914 | — | |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 2,015,681 | — | deriv |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 345,705 | — | deriv |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 970,873 | — | deriv |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 76,969 | — | deriv |
| 16 Sept 2024 | CONVERSION | MBX Biosciences, Inc. | 1,396,762 | — | deriv |
| 12 Sept 2024 | GRANT_AWARD | MBX Biosciences, Inc. | 120,436 | 0.00 USD | deriv |
| 29 Jan 2018 | GRANT_AWARD | MetaVia Inc. | 10,800 | 0.00 USD | deriv |
| 10 Mar 2017 | PURCHASE | MetaVia Inc. | 25,000 | 9.47 USD | |
| 10 Mar 2017 | PURCHASE | MetaVia Inc. | 18,750 | 9.47 USD | deriv |
| 10 Aug 2016 | CONVERSION | MetaVia Inc. | 7,457 | — | |
| 10 Aug 2016 | OTHER | MetaVia Inc. | 816 | 6.71 USD | |
| 10 Aug 2016 | PURCHASE | MetaVia Inc. | 25,000 | 10.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 04 Feb 2025.